This review considers the pharmacological management of rheumatoid arthritis including the role of anti-tumour necrosis factor alpha (TNF) agents, as a precursor to highlighting some of the issues for podiatrists involved in the care of patients on this particular medication.
- rheumatoid arthritis
- anti-TNF therapy
Otter, S., & Cyer, J. R. (2004). Biologic agents used to treat rheumatoid arthritis and their relevance to podiatrists: a practice update. Musculoskeletal Care, 2(1), 51-59. https://doi.org/10.1002/msc.56